Alex Toker

机构：Beth Israel Deaconess Medical Center, Harvard University, Hadassah Medical Center, BioHybrid Solutions (United States) · ORCID：0000-0003-0723-4419

发表论文 425 篇 · 总被引 27646 次 · h-index 80

代表论文

• Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer (2024 · Cancer Research · 被引 35)
• PI3K signaling through a biochemical systems lens (2023 · Journal of Biological Chemistry · 被引 24)
• Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation (2024 · Science Signaling · 被引 14)
• Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity (2025 · Molecular Cell · 被引 7)
• Parallel phosphoproteomics and metabolomics map the global metabolic tyrosine phosphoproteome (2024 · Proceedings of the National Academy of Sciences · 被引 7)
• The glycosyltransferase ALG3 is an AKT substrate that regulates protein N-glycosylation (2025 · Journal of Biological Chemistry · 被引 6)